DOI: 10.1055/s-00000004

Aktuelle Neurologie

References

Phase III.
Clinical trial using daclizumab for relapsing-remitting multiple sclerosis inititated.

Immunotherapy 2010;
2: 437

Download Bibliographical Data

Search in:
Access: